We are live on
!
Find out more
AC
AKO Capital Portfolio holdings
AUM
$5.11B
1-Year Est. Return
2.56%
This Fund
S&P 500
This Quarter
Est. Return
+10.85%
1 Year Est. Return
-2.56%
3 Year Est. Return
+42.63%
5 Year Est. Return
+64.88%
10 Year Est. Return
–
AUM
$3.93B
AUM Growth
+$622M
(+19%)
Cap. Flow
+$257M
Cap. Flow
% of AUM
6.54%
Top 10 Holdings %
Top 10 Hldgs %
63.49%
Holding
21
New
2
Increased
12
Reduced
7
Closed
–
Top Buys
| 1 |
Alcon
ALC
|
+$143M |
| 2 |
CME Group
CME
|
+$60.9M |
| 3 |
Verisk Analytics
VRSK
|
+$35.9M |
| 4 |
Zoetis
ZTS
|
+$31.7M |
| 5 |
Ambev
ABEV
|
+$26.4M |
Top Sells
| 1 |
Ferrari
RACE
|
+$28.1M |
| 2 |
Fair Isaac
FICO
|
+$25.2M |
| 3 |
RTX Corp
RTX
|
+$19.3M |
| 4 |
Moody's
MCO
|
+$13.6M |
| 5 |
Linde
LIN
|
+$11.7M |
Sector Composition
| 1 | Consumer Discretionary | 20.99% |
| 2 | Financials | 17.11% |
| 3 | Healthcare | 14.12% |
| 4 | Consumer Staples | 12.97% |
| 5 | Industrials | 12.66% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Ferrari
RACE
$67.3B
| $485M | 12.33% |
2,992,168
-195,499
| -6% | -$28.1M |
|
|
2
Linde
LIN
$241B
| $394M | 10.03% |
1,963,156
-62,450
| -3% | -$11.7M |
|
|
GRFS
3
Grifois
GRFS
$4.99B
| $265M | 6.74% |
12,562,923
+654,497
| +5% | +$12.5M |
|
4
Visa
V
$694B
| $220M | 5.58% |
1,265,414
+55,692
| +5% | +$9.12M |
|
5
Estee Lauder
EL
$30B
| $215M | 5.45% |
1,171,524
-28,255
| -2% | -$4.83M |
|
6
Allegion
ALLE
$12B
| $195M | 4.97% |
1,767,572
+12,909
| +0.7% | +$1.29M |
|
7
American Express
AXP
$247B
| $184M | 4.68% |
1,492,558
+62,372
| +4% | +$7.33M |
|
|
ANSS
8
DELISTED
Ansys
ANSS
| $184M | 4.68% |
898,998
-42,152
| -4% | -$8.03M |
|
|
9
CME Group
CME
$89B
| $182M | 4.62% |
935,264
+330,305
| +55% | +$60.9M |
|
10
Marriott International
MAR
$97.9B
| $173M | 4.41% |
1,235,952
+22,173
| +2% | +$2.94M |
|
11
Nike
NKE
$66.1B
| $167M | 4.25% |
1,993,021
+35,166
| +2% | +$2.96M |
|
|
12
RTX Corp
RTX
$262B
| $162M | 4.13% |
1,981,297
-230,558
| -10% | -$19.3M |
|
|
13
Fair Isaac
FICO
$28.8B
| $158M | 4.03% |
504,721
-86,815
| -15% | -$25.2M |
|
|
14
Ambev
ABEV
$47.1B
| $151M | 3.84% |
32,360,930
+5,882,307
| +22% | +$26.4M |
|
|
15
Alcon
ALC
$34.4B
| $151M | 3.83% |
+2,434,011
| New | +$143M |
|
16
Procter & Gamble
PG
$353B
| $145M | 3.68% |
1,319,947
+112,063
| +9% | +$11.9M |
|
|
17
Verisk Analytics
VRSK
$26.4B
| $140M | 3.57% |
958,842
+254,336
| +36% | +$35.9M |
|
18
Alphabet (Google) Class C
GOOG
$4.32T
| $134M | 3.41% |
2,479,300
+31,900
| +1% | +$1.84M |
|
19
Edwards Lifesciences
EW
$50.6B
| $105M | 2.68% |
1,710,762
+335,709
| +24% | +$20.3M |
|
|
20
Moody's
MCO
$90.7B
| $87.6M | 2.23% |
448,372
-71,806
| -14% | -$13.6M |
|
|
21
Zoetis
ZTS
$32.2B
| $34.4M | 0.87% |
+303,117
| New | +$31.7M |
|
Similar funds
CIA
EIC
TAM
BG
CS
PA
NC
VT
AKO Capital's Q2 2019 Portfolio in Review
As of Q2 2019, AKO Capital held 21 positions worth $3.93B, up 19% from $3.31B the previous quarter. Its ten largest holdings account for 63% of the portfolio.
AKO Capital deployed $257M of net new capital in Q2 2019, opening 2 new positions and adding to 12 existing holdings. Its largest new stake was Alcon: 2,434,011 shares worth $151M.
By sector, the portfolio is most concentrated in Consumer Discretionary at 21% of assets, down from 22% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was Ferrari, an estimated $28.1M trimmed.
- AKO Capital's largest Q2 2019 buy was Alcon: 2,434,011 shares worth $151M.
- AKO Capital added most to CME Group in Q2 2019, an estimated $60.9M increase.
- AKO Capital's biggest Q2 2019 reduction was Ferrari, cutting an estimated $28.1M.
- AKO Capital's ten largest holdings make up 63% of its $3.93B portfolio in Q2 2019.
- AKO Capital opened 2 new positions and closed 0 in Q2 2019.
- AKO Capital's portfolio value rose 19% quarter-over-quarter to $3.93B.
Based on AKO Capital's 13F filing for Q2 2019, filed 5 Aug 2019.